His role at Ziarco will be to provide input on the company’s corporate, R&D strategy and business plans.
Ziarco Appoints David L. Brinkley to the Board of Directors
His role at Ziarco will be to provide input on the company’s corporate, R&D strategy and business plans.
Tags
Related posts
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
